Stockscreener 앱 받기
6.3786
2.31%
-0.1114
전일 마감가:
$6.49
열려 있는:
$6.32
하루 거래량:
2.28M
Relative Volume:
0.45
시가총액:
$2.28B
수익:
$9.68M
순이익/손실:
$-250.64M
주가수익비율:
-4.5568
EPS:
-1.3998
순현금흐름:
$-89.83M
1주 성능:
-12.31%
1개월 성능:
+23.83%
6개월 성능:
+28.60%
1년 성능:
+242.70%
1일 변동 폭
$6.20
$6.395
1주일 범위
$6.20
$7.32
52주 변동 폭
$2.51
$7.32
Precigen Inc Stock (PGEN) Company Profile
명칭
Precigen Inc
전화
301-556-9900
주소
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Compare PGEN vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PGEN
Precigen Inc
|
6.375 | 2.45B | 9.68M | -250.64M | -89.83M | -1.3998 |
VRTX
Vertex Pharmaceuticals Inc
|
507.66 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
802.17 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.12 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
201.94 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.71 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-15 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2024-03-22 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-05-23 | 개시 | JP Morgan | Neutral |
| 2022-11-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-02-25 | 개시 | Stifel | Buy |
| 2021-02-22 | 개시 | Wells Fargo | Overweight |
| 2021-02-18 | 개시 | B. Riley Securities | Buy |
| 2020-05-08 | 개시 | H.C. Wainwright | Buy |
모두보기
Precigen Inc 주식(PGEN)의 최신 뉴스
Precigen, Inc. (PGEN) Latest Stock News & Headlines - Yahoo! Finance Canada
Can Precigen (PGEN) Justify Its Valuation On Earnings And PAPZIMEOS Launch? - Yahoo Finance
US High Growth Tech Stocks To Watch: 3 Top Picks - simplywall.st
Precigen (PGEN) Q2 2026 Earnings Call Transcript - AOL.com
Precigen (PGEN) Is Up 16.3% After Papsimios-Fueled Return To Profitability And Broad Payer Coverage - webull.com
Precigen (PGEN) Insider Rutul Shah Sells 32,739 Shares - GuruFocus
Precigen jumps 266% on FDA approval but faces h... - Pluang
Wall Street Zen Upgrades Precigen (NASDAQ:PGEN) to "Strong-Buy" - MarketBeat
Precigen: Has To Grow Into Its Valuation - Seeking Alpha
Precigen (NASDAQ:PGEN) COO Sells $224,589.54 in Stock - MarketBeat
COO sale: Precigen (PGEN) insider trades 32,739 shares via plan - Stock Titan
Merck affiliates disclose 4.9% Precigen (NASDAQ: PGEN) ownership - Stock Titan
HC Wainwright Has Positive Outlook for Precigen Q3 Earnings - MarketBeat
Precigen (NASDAQ:PGEN) Stock Rating Upgraded by Zacks Research - MarketBeat
Precigen, Inc. (PGEN) Stock Analysis: Strong Growth Potential With An 80% Upside - DirectorsTalk Interviews
Precigen: 'Strong Buy' Papzimeos Cash-Flow Breakeven In '26, PRGN-2009 Advancement (PGEN) - Seeking Alpha
PRECIGEN, INC. : H.C. WAINWRIGHT RAISES TARGET PRICE TO $18 FROM $14 - webull.com
Precigen (NASDAQ: PGEN) Form 144 covers 32,739 common shares for sale - Stock Titan
HC Wainwright Predicts Precigen's Q4 Earnings (NASDAQ:PGEN) - MarketBeat
Results: Precigen, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - 富途牛牛
Precigen (NASDAQ:PGEN) Reaches New 12-Month HighShould You Buy? - MarketBeat
Arrowstreet Capital Limited Partnership Acquires Shares of 395,695 Precigen, Inc. $PGEN - MarketBeat
Precigen, Inc. (PGEN) Interactive Stock Chart - Yahoo! Finance Canada
Germantown biopharma Precigen turns first quarterly profit after key drug scores FDA approval - The Business Journals
Precigen (NASDAQ:PGEN) Shares Gap Up on Better-Than-Expected Earnings - MarketBeat
Precigen, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Precigen Inc (PGEN) (Q2 2026) Earnings Call Highlights: Revenue Surges 145% and Net Profit Achieved - GuruFocus
Is Precigen Inc (PGEN) Overvalued After Q2 Earnings Beat? GF Sco - GuruFocus
Precigen earnings beat by $0.06, revenue topped estimates - Investing.com
Precigen (NASDAQ:PGEN) Announces Earnings Results - MarketBeat
Precigen, Inc. (PGEN) Q2 Earnings and Revenues Surpass Estimates - Yahoo Finance
Precigen, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Precigen (PGEN) Stock Rises on Q2 2026 Earnings - Quiver Quantitative
Q2 2026 Precigen Inc Earnings Call Transcript - GuruFocus
Earnings Flash (PGEN) Precigen, Inc. Reports Q2 Revenue $55.0M, vs. FactSet Est of $28.0M - marketscreener.com
PGEN: Profitability reached as PAPZIMEOS drives record revenue and broad US adoption - TradingView
PRECIGEN, INC. 2026: Revenue $54.98M, EPS $0.05— 10-Q Summary - TradingView
Precigen Reports Second Quarter 2026 Financial Results Highlighted by Accelerating PAPZIMEOS Revenue Growth - Yahoo Finance
Precigen earnings set to test gene therapy growth trajectory By Investing.com - Investing.com Nigeria
Precigen earnings set to test gene therapy growth trajectory - Investing.com
Analysts Offer Insights on Healthcare Companies: Precigen (PGEN) and Precision BioSciences (DTIL) - The Globe and Mail
Precigen COO Rutul Shah sells $219,518 in company stock - Investing.com
Precigen COO Rutul Shah sells $219,518 in company stock By Investing.com - Investing.com South Africa
Rutul Shah Sells 33,772 Shares of Precigen (NASDAQ:PGEN) Stock - MarketBeat
$Precigen (PGEN.US)$ 🏃🏃 Goodbye, brothers - Moomoo
Precigen (NASDAQ:PGEN) Earns Buy Rating from HC Wainwright - MarketBeat
Precigen, Inc. Revenue Breakdown – NASDAQ:PGEN - TradingView
Precigen, Inc. (PGEN) Investor Outlook: Exploring A Promising 110% Upside In Biotech - DirectorsTalk Interviews
Earnings Preview: Precigen to Report Financial Results Post-market on August 04 - Moomoo
Precigen (PGEN) Projected to Release Earnings on Tuesday - MarketBeat
PGEN|Precigen Inc|Price:5.425|Chg%:+0.025 - TradingKey
Precigen Inc (PGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.01%
자본화:
|
볼륨(24시간):